Perceptive Advisors - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$20,774,000
+24.8%
3,281,914
+52.4%
0.14%
-36.0%
Q1 2021$16,650,000
-1.4%
2,153,974
-16.4%
0.21%
+16.6%
Q4 2020$16,880,000
-1.5%
2,577,0430.0%0.18%
-27.6%
Q3 2020$17,137,000
-20.2%
2,577,0430.0%0.25%
-28.2%
Q2 2020$21,467,000
-14.0%
2,577,043
-20.8%
0.35%
-46.5%
Q1 2020$24,958,000
-7.7%
3,253,9230.0%0.65%
+21.0%
Q4 2019$27,040,000
+12.6%
3,253,9230.0%0.54%
-17.0%
Q3 2019$24,014,000
-32.1%
3,253,923
+3.2%
0.65%
-20.3%
Q2 2019$35,387,000
+3.7%
3,153,923
-0.6%
0.81%
-15.7%
Q1 2019$34,120,000
-21.7%
3,173,923
+9.0%
0.96%
-42.0%
Q4 2018$43,588,000
-11.5%
2,911,715
+9.4%
1.66%
+26.0%
Q3 2018$49,242,000
+12.1%
2,661,715
+38.5%
1.32%
+14.3%
Q2 2018$43,930,000
-30.1%
1,921,715
-13.0%
1.15%
-34.5%
Q1 2018$62,841,000
+19.5%
2,208,812
-11.3%
1.76%
+1.0%
Q4 2017$52,571,000
+4.0%
2,490,381
-10.4%
1.74%
+80.6%
Q3 2017$50,526,000
+134.5%
2,780,762
+100.0%
0.96%
-11.0%
Q2 2017$21,550,000
-18.5%
1,390,381
-9.2%
1.08%
-28.0%
Q1 2017$26,434,000
+160.4%
1,530,659
+65.7%
1.51%
+108.6%
Q4 2016$10,152,000
+33.9%
923,763
+24.5%
0.72%
+37.5%
Q2 2016$7,579,000
-20.8%
742,0210.0%0.52%
-37.5%
Q1 2016$9,572,000
-28.6%
742,021
+15.6%
0.84%
-15.2%
Q4 2015$13,399,000642,0470.99%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$43,106,0001.62%
Altium Capital Management LP 483,041$3,734,0001.04%
RA Capital Management 3,500,000$27,055,0000.41%
Point72 Asset Management, L.P. 6,335,000$48,970,0000.23%
Perceptive Advisors 2,153,974$16,650,0000.21%
RTW INVESTMENTS, LP 1,533,758$11,856,0000.18%
GLOBEFLEX CAPITAL L P 115,647$894,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 785,899$6,075,0000.14%
Affinity Asset Advisors, LLC 50,000$387,0000.13%
Virtus ETF Advisers LLC 38,021$294,0000.12%
View complete list of CYTOMX THERAPEUTICS INC shareholders